Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extension Study to Assess the Long-Term Safety in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products

NCT05010174 is registered in ClinicalTrials.gov with Medeor Therapeutics, Inc. as lead sponsor.

NCT NCT05010174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05010174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extension Study to Assess the Long-Term Safety in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products
Lead sponsor
Medeor Therapeutics, Inc.
Phase
Observational
Overall status
Terminated
Start date
May 11, 2022
Completion date
April 30, 2024
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune tolerance